share_log

Healthcare Services Group Analyst Ratings

Healthcare Services Group Analyst Ratings

医疗服务集团分析师评级
Benzinga ·  2023/08/31 08:43
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
08/31/2023 55.04% Benchmark → $18 Reiterates Buy → Buy
08/01/2023 37.81% RBC Capital → $16 Reiterates Outperform → Outperform
07/27/2023 37.81% RBC Capital $17 → $16 Maintains Outperform
04/28/2023 46.43% Credit Suisse $14 → $17 Maintains Neutral
04/27/2023 46.43% RBC Capital → $17 Reiterates → Outperform
03/24/2023 20.59% Jefferies $8.5 → $14 Upgrades Underperform → Hold
02/21/2023 55.04% Benchmark → $18 Reiterates → Buy
02/17/2023 20.59% Credit Suisse $12 → $14 Maintains Neutral
02/17/2023 46.43% RBC Capital $14 → $17 Upgrades Sector Perform → Outperform
02/13/2023 55.04% Benchmark → $18 Reiterates → Buy
10/20/2022 55.04% Benchmark → $18 Upgrades Hold → Buy
10/20/2022 3.36% Credit Suisse $15 → $12 Maintains Neutral
10/20/2022 20.59% RBC Capital $17 → $14 Maintains Sector Perform
04/21/2022 55.04% Credit Suisse $17 → $18 Maintains Neutral
04/21/2022 72.27% RBC Capital $17 → $20 Maintains Sector Perform
02/10/2022 16.28% Jefferies $19 → $13.5 Downgrades Hold → Underperform
10/22/2021 89.49% Credit Suisse $28 → $22 Maintains Neutral
10/21/2021 72.27% RBC Capital $29 → $20 Maintains Sector Perform
10/20/2021 — William Blair Downgrades Outperform → Market Perform
07/22/2021 149.78% RBC Capital $30 → $29 Maintains Sector Perform
02/11/2021 167.01% Credit Suisse $32 → $31 Maintains Neutral
10/22/2020 123.94% Credit Suisse $31 → $26 Maintains Neutral
07/23/2020 149.78% Baird → $29 Downgrades Outperform → Neutral
07/07/2020 — Northland Capital Markets Downgrades Outperform → Market Perform
07/06/2020 — Benchmark Downgrades Buy → Hold
04/22/2020 132.56% Credit Suisse $32 → $27 Maintains Outperform
04/22/2020 80.88% RBC Capital $26 → $21 Maintains Sector Perform
04/20/2020 141.17% Baird → $28 Upgrades Neutral → Outperform
11/22/2019 123.94% RBC Capital → $26 Initiates Coverage On → Sector Perform
10/23/2019 192.85% Benchmark $37 → $34 Reiterates → Buy
07/24/2019 270.37% Sidoti & Co. $51 → $43 Maintains Buy
07/24/2019 201.46% Credit Suisse $41 → $35 Maintains Outperform
07/12/2019 175.62% Jefferies $40 → $32 Downgrades Buy → Hold
05/01/2019 158.4% Stifel $33 → $30 Maintains Sell
日期 上行/下行 分析公司 目标价格变化 评级变化 上一次/当前评级
2023年08月31日 55.04% 基准 →$18 重申 购买→购买
08/01/2023 37.81% 加拿大皇家银行资本 →$16 重申 跑赢→跑赢大盘
07/27/2023 37.81% 加拿大皇家银行资本 $17→$16 维护 跑赢大盘
04/28/2023 46.43% 瑞士信贷 $14→$17 维护 中性
04/27/2023 46.43% 加拿大皇家银行资本 →$17 重申 →跑赢大盘
03/24/2023 20.59% 杰富瑞 $8.5→$14 升级 表现不佳的→保持
02/21/2023 55.04% 基准 →$18 重申 →购买
02/17/2023 20.59% 瑞士信贷 $12→$14 维护 中性
02/17/2023 46.43% 加拿大皇家银行资本 $14→$17 升级 行业表现优于→
02/13/2023 55.04% 基准 →$18 重申 →购买
10/20/2022 55.04% 基准 →$18 升级 持有→购买
10/20/2022 3.36% 瑞士信贷 $15→$12 维护 中性
10/20/2022 20.59% 加拿大皇家银行资本 $17→$14 维护 行业表现
04/21/2022 55.04% 瑞士信贷 $17→$18 维护 中性
04/21/2022 72.27% 加拿大皇家银行资本 $17→$20 维护 行业表现
02/10/2022 16.28% 杰富瑞 $19→$13.5 评级下调 持有→表现不佳
10/22/2021 89.49% 瑞士信贷 $28→$22 维护 中性
2021/10/21 72.27% 加拿大皇家银行资本 $29→$20 维护 行业表现
10/20/2021 - 威廉·布莱尔 评级下调 跑赢→市场表现
07/22/2021 149.78% 加拿大皇家银行资本 $30→$29 维护 行业表现
02/11/2021 167.01% 瑞士信贷 $32→$31 维护 中性
10/22/2020 123.94% 瑞士信贷 $31→$26 维护 中性
07/23/2020 149.78% 贝尔德 →$29 评级下调 跑赢→中性
07/07/2020 - 北国资本市场 评级下调 跑赢→市场表现
07/06/2020 - 基准 评级下调 购买→Hold
04/22/2020 132.56% 瑞士信贷 $32→$27 维护 跑赢大盘
04/22/2020 80.88% 加拿大皇家银行资本 $26→$21 维护 行业表现
04/20/2020 141.17% 贝尔德 →$28 升级 中性→表现优异
2019年11月22日 123.94% 加拿大皇家银行资本 →$26 开始承保 →行业表现
2019年10月23日 192.85% 基准 $37→$34 重申 →购买
2019年07月24日 270.37% 西多蒂公司 $51→$43 维护 买
2019年07月24日 201.46% 瑞士信贷 $41→$35 维护 跑赢大盘
2019年07月12日 175.62% 杰富瑞 $40→$32 评级下调 购买→Hold
2019年05月01日 158.4% Stifel $33→$30 维护 卖

What is the target price for Healthcare Services Group (HCSG)?

医疗服务集团(HCSG)的目标价格是多少？

The latest price target for Healthcare Services Group (NASDAQ: HCSG) was reported by Benchmark on August 31, 2023. The analyst firm set a price target for $18.00 expecting HCSG to rise to within 12 months (a possible 55.04% upside). 13 analyst firms have reported ratings in the last year.

医疗服务集团(纳斯达克：HCSG)的最新目标价是由Benchmark于2023年8月31日报道的。这家分析公司将目标价定为18.00美元，预计HCSG将在12个月内上涨至55.04%(可能上涨55.04%)。过去一年，有13家分析公司公布了评级。

What is the most recent analyst rating for Healthcare Services Group (HCSG)?

医疗服务集团(HCSG)的最新分析师评级是多少？

The latest analyst rating for Healthcare Services Group (NASDAQ: HCSG) was provided by Benchmark, and Healthcare Services Group reiterated their buy rating.

医疗保健服务集团(纳斯达克：HCSG)的最新分析师评级由Benchmark提供，医疗保健服务集团重申其买入评级。

When is the next analyst rating going to be posted or updated for Healthcare Services Group (HCSG)?

医疗服务集团(HCSG)的下一次分析师评级将于何时发布或更新？

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Healthcare Services Group, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Healthcare Services Group was filed on August 31, 2023 so you should expect the next rating to be made available sometime around August 31, 2024.

分析师在进行了广泛的研究后得出股票评级，其中包括查阅公共财务报表，与医疗保健服务集团的高管和客户交谈，以及听取收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。医疗服务集团的上一次评级是在2023年8月31日提交的，所以你应该预计下一次评级将在2024年8月31日左右的某个时候公布。

Is the Analyst Rating Healthcare Services Group (HCSG) correct?

分析师对医疗服务集团(HCSG)的评级正确吗？

While ratings are subjective and will change, the latest Healthcare Services Group (HCSG) rating was a reiterated with a price target of $0.00 to $18.00. The current price Healthcare Services Group (HCSG) is trading at is $11.61, which is within the analyst's predicted range.

虽然评级是主观的，并将发生变化，但最新的医疗服务集团(HCSG)评级被重申，目标价在0.00美元至18.00美元之间。医疗保健服务集团(HCSG)目前的交易价格为11.61美元，在分析师的预测范围内。

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发